BTMD RSI Chart
Last 7 days
-6.0%
Last 30 days
4.2%
Last 90 days
22.9%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 187.3M | 0 | 0 | 0 |
2023 | 172.7M | 180.6M | 184.1M | 185.4M |
2022 | 145.0M | 151.6M | 158.0M | 165.0M |
2021 | 122.3M | 128.0M | 133.7M | 139.4M |
2020 | 0 | 0 | 0 | 116.6M |
2019 | 0 | 0 | 0 | 110.0M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Jul 05, 2023 | conlon mary elizabeth | sold | -40,573 | 6.5021 | -6,240 | general counsel |
Jun 30, 2023 | conlon mary elizabeth | acquired | - | - | 24,231 | general counsel |
Jun 30, 2023 | cone stephen mark | acquired | - | - | 6,058 | - |
Jun 30, 2023 | jacoby dana lynn | acquired | - | - | 6,058 | - |
Jun 09, 2023 | roystone capital management lp | acquired | - | - | 99,372 | - |
Apr 04, 2023 | conlon mary elizabeth | sold | -64,382 | 5.9246 | -10,867 | general counsel |
Mar 31, 2023 | conlon mary elizabeth | acquired | - | - | 39,375 | general counsel |
Mar 31, 2023 | cone stephen mark | acquired | - | - | 9,844 | - |
Mar 31, 2023 | jacoby dana lynn | acquired | - | - | 9,844 | - |
Feb 07, 2023 | roystone capital management lp | bought | 1,218,750 | 3.25 | 375,000 | - |
Which funds bought or sold BTMD recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | JANE STREET GROUP, LLC | sold off | -100 | -78,595 | - | -% |
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -38.93 | -3,221 | 8,161 | -% |
May 15, 2024 | Royal Bank of Canada | reduced | -42.25 | -29,000 | 62,000 | -% |
May 15, 2024 | STATE STREET CORP | added | 7.4 | 329,160 | 1,590,240 | -% |
May 15, 2024 | MORGAN STANLEY | reduced | -5.11 | 35,511 | 346,667 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | reduced | -43.54 | -153,446 | 301,785 | -% |
May 15, 2024 | BARCLAYS PLC | reduced | -23.61 | -21,000 | 175,000 | -% |
May 15, 2024 | 325 CAPITAL LLC | unchanged | - | 3,239,330 | 21,846,700 | 10.09% |
May 15, 2024 | B. Riley Asset Management, LLC | sold off | -100 | -95,577 | - | -% |
May 15, 2024 | SW Investment Management LLC | reduced | -25.93 | -434,500 | 2,900,000 | 0.93% |
Unveiling Biote Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Biote Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 482.9B | 379.5B | 31.44 | 1.27 | ||||
CI | 96.2B | 206.0B | 24.97 | 0.47 | ||||
HCA | 84.6B | 66.7B | 15.46 | 1.27 | ||||
CVS | 72.4B | 360.9B | 9.89 | 0.2 | ||||
CNC | 41.7B | 155.5B | 15.24 | 0.27 | ||||
DVA | 12.3B | 12.3B | 15.03 | 0.99 | ||||
UHS | 11.9B | 14.7B | 14.63 | 0.81 | ||||
MID-CAP | ||||||||
CHE | 8.5B | 2.3B | 30.15 | 3.73 | ||||
ACHC | 6.2B | 3.0B | -545.12 | 2.06 | ||||
AMEH | 2.3B | 1.5B | 36.62 | 1.57 | ||||
AMN | 2.2B | 3.5B | 15.49 | 0.64 | ||||
SMALL-CAP | ||||||||
ADUS | 1.8B | 1.1B | 27.59 | 1.67 | ||||
BKD | 1.3B | 3.0B | -7.66 | 0.44 | ||||
BEAT | 54.5M | - | -3.61 | - | ||||
AMS | 22.0M | 21.6M | 39.79 | 1.02 |
Biote Corp News
Income Statement (Quarterly) | ||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2019Q4 |
Revenue | 2.4% | 46,804 | 45,703 | 45,557 | 49,257 | 44,843 | 44,485 | 41,970 | 41,359 | 37,143 | 37,536 | 35,567 | 34,750 | - | - | - |
Cost Of Revenue | - | - | - | - | - | - | - | - | - | 12,277 | - | - | - | 11,361 | - | - |
S&GA Expenses | -12.1% | 23,010 | 26,190 | 23,791 | 25,760 | 23,085 | 21,758 | 20,818 | 113,425 | 15,103 | 15,953 | 12,311 | 11,327 | 9,463 | - | - |
EBITDA Margin | 140.7% | 0.16* | 0.07* | 0.08* | -0.05* | -0.12* | 0.05* | -0.01* | 0.04* | 0.25* | 0.26* | 0.25* | 0.26* | 0.27* | 0.28* | 0.22* |
Interest Expenses | -9.1% | 2,230 | 2,454 | 2,441 | 2,351 | 2,230 | 1,938 | 1,506 | 678 | 304 | 313 | 355 | 302 | 492 | - | - |
Income Taxes | 191.1% | 2,500 | -2,744 | 3,900 | 922 | 630 | 437 | 234 | -346 | 64.00 | 77.00 | 67.00 | 78.00 | 64.00 | - | - |
Earnings Before Taxes | -135.6% | -3,324 | 9,334 | 23,516 | -12,173 | -20,800 | 13,245 | 728 | -21,675 | 9,414 | 5,557 | 8,604 | 9,839 | 8,905 | - | - |
EBT Margin | 14051.5% | 0.09* | 0.00* | 0.02* | -0.11* | -0.17* | 0.01* | -0.04* | 0.01* | 0.23* | 0.24* | 0.22* | 0.23* | 0.24* | 0.25* | 0.19* |
Net Income | -130.5% | -5,810 | 19,023 | 7,530 | -13,095 | -21,430 | 1,622 | 15.00 | -2,606 | 9,350 | 5,480 | 8,537 | 9,761 | 8,841 | - | - |
Net Income Margin | 194.9% | 0.04* | -0.04* | -0.14* | -0.18* | -0.13* | -0.01* | 0.04* | 0.08* | 0.23* | 0.23* | 0.20* | 0.15* | 0.24* | 0.25* | 0.19* |
Free Cashflow | -6.3% | 6,668 | 7,115 | -291 | 6,770 | 12,930 | 6,046 | 6,393 | -28,636 | 6,707 | 9,406 | 6,569 | 8,482 | 7,815 | - | - |
Balance Sheet | |||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 |
Assets | 3.1% | 160 | 155 | 150 | 139 | 119 | 112 | 110 | 115 | 59.00 | 54.00 | 318 | 318 | 319 | 33.00 |
Current Assets | -6.5% | 114 | 122 | 118 | 112 | 107 | 101 | 101 | 106 | 52.00 | 47.00 | 1.00 | 1.00 | 2.00 | 28.00 |
Cash Equivalents | -11.5% | 79.00 | 89.00 | 66.00 | 68.00 | 88.00 | 79.00 | 77.00 | 83.00 | 28.00 | 27.00 | 0.00 | 0.00 | 21.00 | 17.00 |
Inventory | 9.3% | 19.00 | 17.00 | 11.00 | 7.00 | 10.00 | 11.00 | 10.00 | 10.00 | 9.00 | 10.00 | - | - | - | 4.00 |
Net PPE | 79.9% | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | - | - | - | 2.00 |
Liabilities | 6.9% | 205 | 192 | 201 | 212 | 203 | 170 | 180 | 187 | 49.00 | 50.00 | 22.00 | 25.00 | 39.00 | 50.00 |
Current Liabilities | 8.3% | 24.00 | 22.00 | 25.00 | 22.00 | 20.00 | 19.00 | 22.00 | 33.00 | 17.00 | 17.00 | 0.00 | 0.00 | 0.00 | 12.00 |
Long Term Debt | -1.3% | 105 | 107 | 108 | 109 | 111 | 112 | 113 | 115 | - | 32.00 | - | - | - | 37.00 |
LT Debt, Current | 0% | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | - | 5.00 | - | - | - | 5.00 |
LT Debt, Non Current | -100.0% | - | 107 | 108 | 109 | 111 | 112 | 113 | 115 | - | 32.00 | - | - | - | 37.00 |
Shareholder's Equity | -22.9% | -44.90 | -36.55 | - | - | -83.81 | -58.27 | - | - | 11.00 | 4.00 | - | 5.00 | 5.00 | 0.00 |
Retained Earnings | -6.5% | -31.30 | -29.39 | -40.52 | -46.39 | -48.53 | -44.46 | -48.12 | -49.14 | 11.00 | 4.00 | -21.45 | -24.45 | -37.69 | -17.05 |
Additional Paid-In Capital | - | - | - | - | - | - | - | - | - | 0.00 | - | - | - | 9.00 | 0.00 |
Shares Outstanding | 34.7% | 35.00 | 26.00 | 30.00 | 21.00 | 18.00 | 8.00 | 8.00 | 8.00 | - | - | - | - | - | - |
Minority Interest | -32.9% | -9.50 | -7.15 | -10.74 | -26.83 | -35.27 | -13.81 | -22.73 | -22.17 | - | - | - | - | - | - |
Float | - | - | - | - | 169 | - | - | - | 8.00 | - | - | - | 307 | - | - |
Cashflow (Quarterly) | |||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2019Q4 |
Cashflow From Operations | 6.0% | 7,372 | 6,956 | 160 | 6,775 | 12,992 | 6,051 | 6,393 | -28,570 | 6,969 | 10,080 | 6,322 | 9,361 | 7,957 | - | - | - |
Share Based Compensation | -11.7% | 1,763 | 1,997 | 2,243 | 2,647 | 2,170 | 2,164 | 746 | 79,270 | - | - | - | - | - | - | - | - |
Cashflow From Investing | -164.1% | -12,176 | 18,996 | -484 | -20,845 | -380 | -311 | -387 | -658 | -482 | -1,047 | -1,329 | -946 | -485 | - | - | - |
Cashflow From Financing | -114.2% | -5,409 | -2,525 | -2,562 | -5,058 | -4,235 | -3,976 | -11,262 | 84,260 | -5,562 | -5,190 | -4,686 | -6,875 | -3,592 | 1.00 | 250* | - |
Dividend Payments | -100.0% | - | 1,106 | 1,000 | 3,495 | 3,093 | 2,276 | 1,903 | 5,972 | 2,735 | - | - | - | - | - | - | - |
CONDENSED CONSOLIDATED STATEMENTS OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenue | ||
Total revenue | $ 46,804 | $ 44,843 |
Cost of revenue | ||
Cost of revenue | 13,367 | 13,877 |
Selling, general, and administrative | 23,010 | 23,085 |
Income from operations | 10,427 | 7,881 |
Other income (expense) net : | ||
Interest expense, net | (1,660) | (1,646) |
Loss from change in fair value of warrant liability | (1,618) | |
Loss from change in fair value of earnout liability | (12,089) | (25,410) |
Other income (expense) | (2) | (7) |
Total other income (expense), net | (13,751) | (28,681) |
Loss before provision for income taxes | (3,324) | (20,800) |
Income tax expense | 2,486 | 630 |
Net loss | (5,810) | (21,430) |
Less: Net loss attributable to noncontrolling interest | (3,740) | (14,625) |
Net loss attributable to biote Corp. stockholders | (2,070) | (6,805) |
Other comprehensive income (loss): | ||
Foreign currency translation adjustments | (1) | |
Other comprehensive income (loss) | (1) | |
Comprehensive income (loss) | $ (5,811) | $ (21,430) |
Net loss per common share | ||
Basic | $ (0.06) | $ (0.39) |
Diluted | $ (0.06) | $ (0.39) |
Weighted average common shares outstanding | ||
Basic | 34,621,166 | 17,585,045 |
Diluted | 34,621,166 | 17,585,045 |
Product Revenue | ||
Revenue | ||
Total revenue | $ 46,035 | $ 44,155 |
Cost of revenue | ||
Cost of revenue | 12,802 | 13,027 |
Service Revenue | ||
Revenue | ||
Total revenue | 769 | 688 |
Cost of revenue | ||
Cost of revenue | $ 565 | $ 850 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 78,787 | $ 89,002 |
Accounts receivable, net | 8,022 | 6,809 |
Inventory, net | 18,917 | 17,307 |
Other current assets | 8,635 | 9,225 |
Total current assets | 114,361 | 122,343 |
Property and equipment, net | 2,191 | 1,218 |
Capitalized software, net | 4,930 | 4,973 |
Goodwill | 5,525 | |
Intangible assets, net | 6,015 | |
Operating lease right-of-use assets | 2,202 | 1,877 |
Deferred tax asset | 24,884 | 24,884 |
Total assets | 160,108 | 155,295 |
Current liabilities | ||
Accounts payable | 4,196 | 4,155 |
Accrued expenses | 9,729 | 8,497 |
Term loan, current | 6,250 | 6,250 |
Deferred revenue, current | 2,876 | 3,002 |
Earnout liabilities, current | 600 | |
Operating lease liabilities, current | 406 | 311 |
Total current liabilities | 24,057 | 22,215 |
Term loan, net of current portion | 105,270 | 106,630 |
Deferred revenue, net of current portion | 1,426 | 1,322 |
Operating lease liabilities, net of current portion | 1,917 | 1,680 |
TRA liability | 18,894 | 18,894 |
Earnout liabilities, net of current portion | 53,444 | 41,100 |
Total liabilities | 205,008 | 191,841 |
Commitments and contingencies (See Note 19) | ||
Stockholders' Deficit | ||
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued or outstanding as of March 31, 2024 and December 31, 2023 | ||
Additional paid-in capital | 0 | 0 |
Accumulated deficit | (31,303) | (29,391) |
Accumulated other comprehensive loss | (14) | (12) |
Treasury stock, at cost | (4,088) | |
biote Corp.'s stockholders' deficit | (35,399) | (29,397) |
Noncontrolling interest | (9,501) | (7,149) |
Total stockholders' deficit | (44,900) | (36,546) |
Total liabilities and stockholders' deficit | 160,108 | 155,295 |
Class A Common Stock | ||
Stockholders' Deficit | ||
Common stock value | 3 | 3 |
Class V Common Stock | ||
Stockholders' Deficit | ||
Common stock value | $ 3 | $ 3 |